HER2 positive solid tumor
Clinical trials for HER2 positive solid tumor explained in plain language.
Never miss a new study
Get alerted when new HER2 positive solid tumor trials appear
Sign up with your email to follow new studies for HER2 positive solid tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for HER2 cancers: first human trial launches
Disease control Recruiting nowThis early-phase trial tests an experimental drug called YH32367 in people with HER2-positive solid tumors that have spread or cannot be removed by surgery. The study has two parts: first, finding a safe dose, then testing that dose in specific cancer types like biliary tract can…
Matched conditions: HER2 POSITIVE SOLID TUMOR
Phase 1/2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New imaging trick could sharpen cancer scans
Diagnosis Recruiting nowThis early-phase study tests a new imaging agent (TGW211) in 19 adults with HER2-positive solid tumors. The goal is to see if a special 'trigger' can help clear the imaging tracer from healthy tissues faster, making tumor scans clearer. The study focuses on safety and image quali…
Matched conditions: HER2 POSITIVE SOLID TUMOR
Early phase 1 • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC